»ó´Ü¿©¹é
±â»ç (Àüü 101°Ç)
[Sub Story] ¹Ì¡¤À¯·´ °íÇ÷¾Ð °¡À̵å Àû¿ëÇϸ顦 ÀÌ»óµ· ±âÀÚ 2020-11-02 14:42
[Conference Report] ³·Àº ¸ñÇ¥Ç÷¾Ð¡¤Á¶Àý·ü¿¡ º´¿ë¡¤º¹ÇÕÁ¦ ¿ä±¸ Áõ´ë ÀÌ»óµ· ±âÀÚ 2020-08-13 16:13
[Drug Review] Ç÷´ç¡¤ÄÝ·¹½ºÅ×·Ñ µ¿½Ã°ø·« ¼øÀÀµµ ÀÌ»ó¹« ÀÌ»óµ· ±âÀÚ 2020-07-25 14:24
[Conference Report] ÃÖÀû Ç÷¾ÐÄ¡·á »õ ±âÁØ Á¦½Ã ÀÌ»óµ· ±âÀÚ 2020-01-30 10:50
[Conference Report] Ç×°íÇ÷¾ÐÁ¦ Ä¡·á Ç÷¾ÐÁ¶Àý¿¡¼­ ½ÉÇ÷°ü º¸È£ È¿°ú±îÁö ÀÌ»óµ· ±âÀÚ 2020-01-02 17:12
¶óÀÎ
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ýÀÇ ½ÉÇ÷°ü ÀÓ»óÇýÅÃÀº? ÀÌ»óµ· ±âÀÚ 2020-01-02 17:09
[Sub Story] Ç÷¾Ð ´õ ³·Ãß·Á¸é, Ç×°íÇ÷¾ÐÁ¦ ´õ ÇÊ¿äÇÏ´Ù ÀÌ»óµ· ±âÀÚ 2020-01-02 17:09
[Cover Story] °íÇ÷¾Ð Ä¡·áÀÇ »õ Æз¯´ÙÀÓ ÀÌ»óµ· ±âÀÚ 2020-01-02 17:09
[Conference Report] Á¶Àý·ü ¿Ã¸®°í ½ÉÇ÷°üÁúȯ ³·Ãß·Á¸é¡¦ ÀÌ»óµ· ±âÀÚ 2020-01-02 14:22
[Interview] ¡°ESC, °í¡¤ÃÊ°íÀ§Çè ´ç´¢º´ ȯÀÚµµ LDL-C 50% ÀÌ»ó ³·Ãç¾ß¡± ÀÓ¼¼Çü ±âÀÚ 2019-12-03 15:06
¶óÀÎ
[Interview] ¼Õ½¬¿î º¹ÇÕÁ¦ ó¹æ ´Ã¸é Á¶Àý·ü Àçµµ¾à ±âȸ ¿Ã °Í ÀÌ»óµ· ±âÀÚ 2019-10-08 15:54
[Cover Story] ¡®´ÙÁ¦¾à¹°¿ä¹ý¡¯ ½Ã´ë ¼ÒÀÓ ´ÙÇؾß! ÀÌ»óµ· ±âÀÚ 2019-10-08 15:53
[Sub Story] º´¿ë½Ã±â °¥¼ö·Ï »¡¶óÁ® ÀÌ»óµ· ±âÀÚ 2019-10-08 15:46
[Interview] ¼øÀÀµµ ³ôÀÌÀÚ°í ¸¸µç Ç÷¾Ð¡¤ÁöÁúÄ¡·á ¡®SPC¡¯ ÀÌ»óµ· ±âÀÚ 2019-10-08 12:20
[Interview] ¡°´ç´¢º´ ȯÀÚ ÁöÁúÄ¡·á LDL¡¤TG¡¤HDL ¸ðµÎ °ø·«Çؾߡ± ÀÌ»óµ· ±âÀÚ 2019-07-31 17:04
¶óÀÎ
[Sub Story] ¡°¾à ³Ê¹« ¸¹¾Æ Èûµé´Ù¡± ÀÌ»óµ· ±âÀÚ 2019-07-31 10:32
[Conference Report] Ä«³ªºê Æйи®, ó¹æ½ÃÀå ¼¼°è·Î È®´ë ÀÓ¼¼Çü ±âÀÚ 2019-07-31 09:31
[Sub Story] 2018 À¯·´½ÉÀåÇÐȸ¡¤°íÇ÷¾ÐÇÐȸ °íÇ÷¾Ð °ü¸® °¡À̵å¶óÀÎ THE MOST 2018-11-08 16:12
[Sub Story] SPRINT ¿¬±¸ ÅëÇØ º» ¿ø³»¡¤Áø·á½Ç Ç÷¾ÐÃøÁ¤¹ýÀÇ ÇöÀç¿Í ¹Ì·¡ THE MOST 2018-11-08 15:47
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ 1Â÷Ä¡·á: º£Å¸Â÷´ÜÁ¦ THE MOST 2018-11-08 14:44
Back to Top